Definitive Contract W81XWH17C0053
Award Date 5/15/17
Potential Completion Date 10/14/19
Potential Value $999K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Penn State University, PA 16802, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
STTR Phase II
Primary Consortia Member
Not listed Similar Awards
- This contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, a for-profit small business manufacturer of medical devices and technologies. The $999,871.34 fixed-price level of effort contract is for Phase II of a Small Business Innovation Research (SBIR) project to develop blood purification technologies. Cytosorbents, as the prime contractor, is providing research and prototype development services to the Defense Health...
- Cytosorbents Medical Inc., doing business as Cytosorbents, was awarded a $2.9 million firm fixed price contract from the Department of the Army Medical Command to develop a highly efficient adsorber to remove anti-A and anti-B antibodies from blood and plasma for transfusion under a Small Business Technology Transfer Research Phase III solicitation. This definitive contract is a follow-on to previous STTR research awards and will support Cytosorbents' continued medical research and development...
- This is a $999,996.59 firm-fixed-price Phase II SBIR contract awarded by the Joint PEO Chemical and Biological Defense to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for research and prototype development services related to Cytosorbents' blood purification technologies, including an extracorporeal cytokine adsorber, a potassium adsorber, and a blood group antibody adsorber. These technologies are intended to treat critical care...
- This is a firm fixed-price purchase order awarded by the Joint Program Executive Office for Chemical and Biological Defense, a U.S. Department of Defense agency, to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The $149,935.98 contract is for research and prototype development services under the Small Business Innovation Research (SBIR) Phase I program. The contract is set aside for small businesses. Cytosorbents Medical Inc., the prime contractor,...
- This federal contract award, with a ceiling value of $149,927.17, was issued by the U.S. Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for a SBIR Phase I research project under the Defense Health Program (DHP), with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business set-aside, Cytosorbents is the prime contractor responsible for conducting the research to...
- This is a $149,979 firm-fixed-price Definitive Contract awarded by the United States Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract was awarded under the Small Business Innovation Research (STTR) program for Phase I research, with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business, this contract award was set aside for Cytosorbents as the prime...
- This $1.1 million firm fixed price contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, to support research and development of an adsorber to remove anti-A and anti-B antibodies from plasma for transfusion under the Small Business Innovation Research (SBIR) Program Phase II solicitation. As a total small business set-aside, the contract aims to further the prime contractor's development of an effective adsorber that...
- Cytosorbents Medical Inc., doing business as Cytosorbents and classified as a small disadvantaged business, has been awarded a $74,918 firm fixed price purchase order by the Department of the Air Force Materiel Command Research Laboratory. The contract is set aside for total small business and involves research and development of a novel sorbent technology for the rapid treatment of acute joint injury and inflammation under the Small Business Innovation Research Program Phase I. Work will be...
- The U.S. Army Medical Command awarded a $4.3M Phase III Small Business Innovation Research (SBIR) contract to Cytosorbents Medical Inc. on August 22, 2022, for research and development of a universal dried plasma product designed for battlefield and first responder use. The contract, which carries a firm fixed-price structure and is set aside for small business, focuses on integrating isoagglutinin reduction technology to enable universal blood transfusions in emergency and combat scenarios....
- This federal contract award was made by the National Heart Lung and Blood Institute, a civilian agency, to Cytobank, Inc., a small business, for a SBIR Phase I project titled "A Cloud Computing Platform for Cytometry." The $153,813 Firm Fixed Price contract was awarded on September 23, 2011 with a completion date of March 22, 2012. The project falls under the SBIR (Small Business Innovation Research) program, which supports research and development by small businesses. This Phase I...